LeadIQ logo
Learn more at LeadIQ.com

Insights

Expanding Product Portfolio Sera Prognostics is actively developing new maternal and neonatal health tests, including a self-collection device for the PreTRM Test, which creates opportunities to offer complementary diagnostic tools to healthcare providers and expand market penetration.

Leadership Growth Recent appointments of key medical and commercial leaders, such as the Chief Medical Officer and Chief Commercial Officer, suggest strategic initiatives to accelerate adoption of their biomarker tests, opening avenues for targeted outreach and personalized sales approaches.

Market Engagement Participation in high-profile healthcare conferences indicates a focus on building relationships with healthcare professionals and industry stakeholders, which can be leveraged to introduce new products and expand distribution channels.

Funding and Revenue With significant funding of 136 million dollars and a current revenue range of up to 1 million dollars, Sera Prognostics potentially seeks strategic partnerships or sales channels to scale their innovative tests in prenatal care markets.

Industry Positioning Positioned among biotech firms focused on pregnancy and neonatal health, Sera Prognostics presents opportunities to collaborate with healthcare providers, insurers, and medical device companies to facilitate test adoption and enhance value-based care solutions.

Sera Prognostics Tech Stack

Sera Prognostics uses 8 technology products and services including WordPress, jQuery UI, jQuery, and more. Explore Sera Prognostics's tech stack below.

  • WordPress
    Content Management System
  • jQuery UI
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Salesforce Marketing Cloud Account Engagement
    Marketing Automation
  • WP Engine
    Platform As A Service
  • PHP
    Programming Languages
  • Nginx
    Web Servers
  • OpenResty
    Web Servers

Media & News

Sera Prognostics's Email Address Formats

Sera Prognostics uses at least 1 format(s):
Sera Prognostics Email FormatsExamplePercentage
FLast@seraprognostics.comJDoe@seraprognostics.com
79%
FirstL@seraprognostics.comJohnD@seraprognostics.com
15%
First@seraprognostics.comJohn@seraprognostics.com
5%
LFirst@seraprognostics.comDJohn@seraprognostics.com
1%

Frequently Asked Questions

Where is Sera Prognostics's headquarters located?

Minus sign iconPlus sign iconSera Prognostics's main headquarters is located at 2749 East Parleys Way Salt Lake City, Utah 84109 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Sera Prognostics's phone number?

Minus sign iconPlus sign icon You can contact Sera Prognostics's main corporate office by phone at
+1-801-990-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sera Prognostics's stock symbol?

Minus sign iconPlus sign iconSera Prognostics is a publicly traded company; the company's stock symbol is SERA.

What is Sera Prognostics's official website and social media links?

Minus sign iconPlus sign iconSera Prognostics's official website is seraprognostics.com and has social profiles on LinkedInCrunchbase.

How much revenue does Sera Prognostics generate?

Minus sign iconPlus sign icon As of March 2026, Sera Prognostics's annual revenue is estimated to be $1.5M.

What is Sera Prognostics's SIC code NAICS code?

Minus sign iconPlus sign iconSera Prognostics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sera Prognostics have currently?

Minus sign iconPlus sign iconAs of March 2026, Sera Prognostics has approximately 83 employees across 2 continents, including North AmericaEurope. Key team members include Chief Information Officer (cio): R. G. H.Chief Commercial Officer (cco): L. A.Chief Financial Officer: A. A.. Explore Sera Prognostics's employee directory with LeadIQ.

What industry does Sera Prognostics belong to?

Minus sign iconPlus sign iconSera Prognostics operates in the Biotechnology Research industry.

What technology does Sera Prognostics use?

Minus sign iconPlus sign iconSera Prognostics's tech stack includes WordPressjQuery UIjQuerySalesforce Marketing Cloud Account EngagementWP EnginePHPNginxOpenResty.

What is Sera Prognostics's email format?

Minus sign iconPlus sign iconSera Prognostics's email format typically follows the pattern of FLast@seraprognostics.com. Find more Sera Prognostics email formats with LeadIQ.

How much funding has Sera Prognostics raised to date?

Minus sign iconPlus sign icon As of March 2026, Sera Prognostics has raised $136M in funding. The last funding round occurred on Apr 01, 2021 for $100M.

When was Sera Prognostics founded?

Minus sign iconPlus sign iconSera Prognostics was founded in 2008.

Sera Prognostics

Biotechnology ResearchUtah, United States51-200 Employees

Sera Prognostics is a leading proteomic and bioinformatics company dedicated to improving the lives of women and babies through precision biomarker-based tests designed to enhance pregnancy care. Our vision is to deliver pivotal information to physicians early in pregnancy to help them to improve the health of their patients and reduce costs of healthcare delivery. 
The PreTRM® Test reports to a physician the individualized risk of premature birth, enabling earlier proactive interventions in patients with higher risk. We're also developing a robust pipeline of innovative tests focused on other complications of pregnancy, including preeclampsia, gestational diabetes, growth restriction, and others.
Learn more about our values, culture, and open positions on our website.

Section iconCompany Overview

Headquarters
2749 East Parleys Way Salt Lake City, Utah 84109 United States
Phone number
+1-801-990-****
Website
seraprognostics.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SERA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $136M

    Sera Prognostics has raised a total of $136M of funding over 2 rounds. Their latest funding round was raised on Apr 01, 2021 in the amount of $100Mas a Series E.

  • $1M

    Sera Prognostics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $136M

    Sera Prognostics has raised a total of $136M of funding over 2 rounds. Their latest funding round was raised on Apr 01, 2021 in the amount of $100Mas a Series E.

  • $1M

    Sera Prognostics's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    R. G. H.
    Chief Information Officer (cio)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. A.
    Chief Commercial Officer (cco)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. A.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. B.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. R.
    Chief Medical Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    G. R.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. L.
    Head Of Growth
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. H.
    Head Of Market Access
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. L.
    Head Of Revenue Cycle And Customer Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. U.
    Head Of Commercial Operations
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.